- Comment on the article: "Calcium channel blockers as a first-line tocolytic?"2003 | Publication without faculty affiliation
- Calcium channel blockers in cardiovascular therapy2003 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- New view on Calcium-channel blockers. What brings the INVEST Study?2003 | Faculty of Medicine in Pilsen
- Calcíum channel blockers and theír current place ín cardíology2011 | Third Faculty of Medicine
- Calcium channel blockers in the treatment of myocardial ischaemia and in atherogenesis - what is new at the beginning of the 21st century2003 | Faculty of Physical Education and Sport
- Calcium channel blockers +12002 | First Faculty of Medicine
- Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?2021 | Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Trends in consumption of calcium channel blockers in the Czech Republic during 1993-1999 and comparison with selected countries: drug utilization study2002 | Third Faculty of Medicine
- Calcium channel blockers in cardiovascular therapy2003 | Faculty of Medicine in Pilsen
- Calcium Channels Blockers2000 | First Faculty of Medicine
- Calcium channel blockers in the treatment of myocardial ischaemia and in atherogenesis - what is new at the beginning of the 21st century2003 | First Faculty of Medicine
- The combinatioon of calcium channel blocker and diuretic in treatment of arterial hypertension2015 | Faculty of Medicine in Pilsen
- Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions2002 | Publication without faculty affiliation
- Pre- and postsynaptic effects of the calcium channel blocker verapamil at neuromuscular junctions2002 | First Faculty of Medicine, Faculty of Mathematics and Physics
- Calcium channel blockers as first choice tokolytics?2003 | Publication without faculty affiliation
- Pre- and postsynaptic effects of the calcium channel blocker Verapamil at neuromuscular junctions2002 | Publication without faculty affiliation
- Calcium channel blockers in the treatment of arterial hypertension2001 | First Faculty of Medicine
- Amlodipin - calcium channel blocker of the 3rd generationPublication without faculty affiliation
- The position of calcium channel blockers in the current pharmacotherapy of heart disease ischaemia and arterial hypertension2002 | First Faculty of Medicine
- Evaluation of calcium channel blockers as potential hepatoprotective agents in oxidative stress injury of perfused hepatocytes2000 | Faculty of Medicine in Hradec Králové
- Evaluation of calcium channel blockers as potential hepatoprotective agents in oxidative stress injury of perfused hepatocytes2000 | First Faculty of Medicine
- Hypertension, vasospastic angina pectoris and calcium channel blocker barnidipine2005 | First Faculty of Medicine
- Wha is amlidipin classified as a calcium channel blocker of 3rd generation?2001 | First Faculty of Medicine
- Calcium channel blockers do not protect against saturated fatty acid-induced ER stress and apoptosis in human pancreatic β-cells2021 | Third Faculty of Medicine
- Lercanidipine in the therapy of hypertension2011 | Third Faculty of Medicine
- Efficacy and acceptability of I1-imidazoline antihypertensive rilmenidine compared to calcium channel blocker isradipine in hypertensive patients with metabolic syndrome XPublication without faculty affiliation
- Nitrendipine and dementia: forgotten positive facts?2018 | Faculty of Medicine in Hradec Králové
- Barnidipine and its pharmacological and clinmical properties2003 | Faculty of Pharmacy in Hradec Králové
- Medical treatment of hypertrophic cardiomyopathy - What do we know about it today?2015 | Third Faculty of Medicine